NDC 65250-260 is a Injection, Suspension, Liposomal in the Drug For Further Processing category. It is labeled and distributed by Pacira Pharmaceuticals Inc..
| Product ID | 65250-260_0577d6c7-5b19-4214-b12f-102c8e7b2d3d |
| NDC | 65250-260 |
| Product Type | Drug For Further Processing |
| Proprietary Name | NDC 65250-260 |
| Dosage Form | Injection, Suspension, Liposomal |
| Marketing Start Date | 2018-09-24 |
| Marketing Category | / DRUG FOR FURTHER PROCESSING |
| Labeler Name | Pacira Pharmaceuticals Inc. |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| BUPIVACAINE | 13.3 mg/mL |